What is the relationship between Fusobacterium nucleatum infection and glutathione (GSH) levels in gastric cancer (GC)?
Label:chem
Topic
Fusobacterium nucleatum (F. nucleatum) is a Gram-negative anaerobic bacterium that has been associated with tumor progression in colorectal cancer (CRC). Recent studies have shown that F. nucleatum is also enriched in gastric cancer (GC) tissues and is linked to poor patient prognosis. Glutathione (GSH) is a critical intracellular antioxidant that maintains redox homeostasis and plays a dual role in cancer progression. The regulatory mechanism of GSH metabolism in GC and its interaction with F. nucleatum remain unclear.
From: "Fusobacterium nucleatum Infection Drives Glutathione Depletion in Gastric Cancer: Integrated Multi-Omics and Experimental Validation", Microorganisms 2025, 13(8), 1907;
Answer
Fusobacterium nucleatum infection in GC tissues is associated with significant depletion of GSH. The study demonstrates that F. nucleatum suppresses the GSH synthesis pathway, leading to a breakdown in antioxidant capacity and the formation of an oxidative stress microenvironment in GC cells. This finding suggests that targeting the F. nucleatum-GSH axis could offer a novel therapeutic strategy for GC treatment.
Return to Home
Chemical List
Knowledge you may be interested in